Found: 18
Select item for more details and to access through your institution.
The N-terminal Region of CXCL11 as Structural Template for CXCR3 Molecular Recognition: Synthesis, Conformational Analysis, and Binding Studies.
- Published in:
- Chemical Biology & Drug Design, 2012, v. 80, n. 2, p. 254, doi. 10.1111/j.1747-0285.2012.01397.x
- By:
- Publication type:
- Article
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8504, doi. 10.3390/ijms23158504
- By:
- Publication type:
- Article
Conformational Ensembles Explored Dynamically from Disordered Peptides Targeting Chemokine Receptor CXCR4.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 6, p. 12159, doi. 10.3390/ijms160612159
- By:
- Publication type:
- Article
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. 1, doi. 10.1186/s13046-019-1420-8
- By:
- Publication type:
- Article
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921989223
- By:
- Publication type:
- Article
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921989223
- By:
- Publication type:
- Article
Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074548
- By:
- Publication type:
- Article
Inhibition of stromal CXCR4 impairs development of lung metastases.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 10, p. 1713, doi. 10.1007/s00262-012-1223-7
- By:
- Publication type:
- Article
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.73396
- By:
- Publication type:
- Article
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.73396
- By:
- Publication type:
- Article
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1849, doi. 10.3390/cancers14071849
- By:
- Publication type:
- Article
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1952, doi. 10.3390/cancers12071952
- By:
- Publication type:
- Article
Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential.
- Published in:
- Molecular Diagnosis & Therapy, 2014, v. 18, n. 4, p. 389, doi. 10.1007/s40291-014-0101-8
- By:
- Publication type:
- Article
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Regulatory T cells, interleukin ( IL)-6, IL-8, Vascular endothelial growth factor ( VEGF), CXCL10, CXCL11, epidermal growth factor ( EGF) and hepatocyte growth factor ( HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
- Published in:
- BJU International, 2013, v. 112, n. 5, p. 686, doi. 10.1111/bju.12068
- By:
- Publication type:
- Article
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 8, p. N.PAG, doi. 10.1038/s41419-019-1796-6
- By:
- Publication type:
- Article
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 12, p. 2016, doi. 10.1038/s41416-024-02702-x
- By:
- Publication type:
- Article
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 21, p. 3340, doi. 10.3390/cells11213340
- By:
- Publication type:
- Article